{"id":"W2016573373","doi":"10.1016/j.jalz.2011.05.2010","title":"O4‐06‐07: Imaging and cerebrospinal fluid biomarker results of a phase II dose‐ranging study of ELND005 (Scyllo‐inositol) in mild‐to‐moderate Alzheimer's disease","year":2011,"lang":"en","type":"article","venue":"Alzheimer s & Dementia","topic":"Alzheimer's disease research and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Interface Biologics (Canada); NeuroRx Research (Canada); University Health Network","funders":"","keywords":"Placebo; Biomarker; Medicine; Cerebrospinal fluid; Clinical endpoint; Internal medicine; Population; Gastroenterology; Amyloid beta; Urology; Nuclear medicine; Pathology; Randomized controlled trial; Disease; Chemistry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001104343,0.001270687,0.001680383,0.000344975,0.0003343439,0.000708233,0.0007356047,0.001357188,0.002491883],"category_scores_gemma":[0.0007837401,0.0004220218,0.0008680795,0.0001960413,0.0006768248,0.0005644563,0.0002607691,0.002119506,0.0005989259],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005704239,"about_ca_system_score_gemma":0.0009700407,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00129978,"about_ca_topic_score_gemma":0.002876885,"domain_scores_codex":[0.9997075,0.0001052024,0.00002135739,0.00004467336,0.0000401113,0.00008112555],"domain_scores_gemma":[0.9994757,0.00008109993,0.00006516103,0.00004684876,0.00005909995,0.0002721412],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.67959,0.1053584,0.006708272,0.0005641216,0.00143306,0.0002573194,0.0002188264,0.001547519,0.1272834,0.000133227,0.00287217,0.07403351],"study_design_scores_gemma":[0.2715853,0.683167,0.02469022,0.0000277151,0.0008762054,0.0002253416,0.00008038887,0.00122625,0.01535636,0.0001374441,0.002574836,0.00005293139],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.997236,0.0006607406,0.0002042004,0.0001451529,0.00003984398,0.0004414255,0.0005792796,0.00005206704,0.0006413056],"genre_scores_gemma":[0.9912761,0.001033092,0.001131078,0.0005402744,0.000112649,0.000671774,0.002405569,0.00002432298,0.002805087],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002491883,"threshold_uncertainty_score":0.008336186,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05466280284312119,"score_gpt":0.3368636798285068,"score_spread":0.2822008769853857,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}